However, by ensuring that at least a proportion of the anti-viral T cell response can also act to boost an anti-tumor response by encoding multiple relevant tumor antigens within the virus the CD8+ T cell response associated with oncolytic virotherapy can be purposed for very effective tumor clearance. This evidence concerns the gene CD8A and neoplasm.